SALE OF MARKETABLE SECURITIES (Details Narrative) - USD ($)		3 Months Ended	9 Months Ended
Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jan. 01, 2011
Investments, Debt and Equity Securities [Abstract]
Number of reatined shares from spin off						5,936,115
Retained shares value				$ 0
Generated net cash from sale		$ 136,557	$ 141,662	$ 742,693	$ 1,006,588
Sale of common stock	100,000			1,100,000	1,245,000
Average price per share		$ 0.68	$ 0.79	$ 0.68	$ 0.79
Shares own of MariMed Inc		650,000		650,000

This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity and any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and/or investments that are separately or otherwise not categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.

No definition available.

Name:	us-gaap_RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration